ALB and nephrotic syndrome: Tacrolimus was reintroduced, but the patient was lost to follow-up until December 2024, when he presented with severe nephrotic syndrome (serum albumin 9 g/L, UPCR 166 mg/mmol, serum creatinine 61 μmol/L).